Drug Type Molecular glue |
Synonyms |
Target |
Mechanism BCL6 inhibitors(B-cell lymphoma 6 protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H31ClF2N6O2 |
InChIKeyVFNPUAOAEFMXQI-GASCZTMLSA-N |
CAS Registry2647503-57-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Large B-Cell Lymphoma | Preclinical | GB | 23 Apr 2020 |